Accès gratuit
Med Sci (Paris)
Volume 20, Numéro 4, Avril 2004
Page(s) 448 - 452
Section M/S revues
Publié en ligne 15 avril 2004
  1. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis : scientific and public health implications. Science 2000; 287 : 607–14.
  2. Peeters M, Courgnaud V, Abela B, et al. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis 2002; 8 : 451–7.
  3. Peeters M, Courgnaud V, Abela B. Genetic diversity of lentiviruses in non-human-primates. AIDS Rev 2001; 3 : 3–10.
  4. Courgnaud V, Salemi M, Pourrut X, et al. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J Virol 2002; 76 : 8298–309.
  5. Souquiere S, Bibollet-Ruche F, Robertson DL, et al. Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol 2001; 75 : 7086–96.
  6. Muller MC, Barre-Sinoussi F. SIVagm : genetic and biological features associated with replication. Front Biosci 2003; 8 : 1170–85.
  7. Popper SJ, Sarr AD, Travers KU, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180 : 1116–21.
  8. Hirsch VM, Johnson PR. Pathogenic diversity of simian immunodeficiency viruses. Virus Res 1994; 32 : 183–203.
  9. Fultz PN, McClure HM, Anderson DC, Switzer WM. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retrovir 1989; 5 : 397–409.
  10. Hirsch VM, Dapolito G, Johnson PR, et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey : species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 1995; 69 : 955–67.
  11. Novembre FJ, Saucier M, Anderson DC, et al. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 1997; 71 : 4086–91.
  12. Kestler HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991; 65 : 651–62.
  13. Mariani R, Kirchhoff F, Greenough TC, et al. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996; 70 : 7752–64.
  14. Novembre FJ, Johnson PR, Lewis MG, et al. Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol 1993; 67 : 2466–74.
  15. Tao B, Fultz PN. Pathogenicity and comparative evolution in vivo of the transitional quasispecies SIVsmmPBj8. Virology 1999; 259 : 166–75.
  16. Rudensey LM, Kimata JT, Long EM, et al. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVmne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol 1998; 72 : 209–17.
  17. Hirsch VM, Sharkey ME, Brown CR, et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj : evidence of macrophage-dependent viral amplification. Nat Med 1998; 4 : 1401–8.
  18. Courgnaud V, Laure F, Fultz PN, et al. Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. J Virol 1992; 66 : 414–9.
  19. Chakrabarti LA, Ivanovic T, Cheng-Mayer C. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones. J Virol 2002; 76 : 1588–99.
  20. Liu HY, Soda Y, Shimizu N, et al. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses. Virology 2000; 278 : 276–88.
  21. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science 2001; 292 : 1106–9.
  22. Courgnaud V, Saurin W, Villinger F, Sonigo P. Different evolution of simian immunodeficiency virus in a natural host and a new host. Virology 1998; 247 : 41–50.
  23. Muller-Trutwin MC, Corbet S, Tavares MD, et al. The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo. Virology 1996; 223 : 89–102.
  24. Estaquier J, Monceaux V, Cumont MC, et al. Early changes in peripheral blood T cells during primary infection of Rhesus macaques with a pathogenic SIV. J Med Primatol 2000; 29 : 127–35.
  25. Ploquin M, Diop O, Roques P, et al. Facteurs de non-pathogénicité de l’infection à SIVagm chez le singe vert d’Afrique. Virologie 2003; 7 : 1–9.
  26. Bostik P, Wu P, Dodd GL, et al. Identification of protein kinases dysregulated in CD4(+) T cells in pathogenic versus apathogenic simian immunodeficiency virus infection. J Virol 2001; 75 : 11298–306.
  27. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003; 18 : 441–52.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.